J&J Beats Investor's Suit Over Talc-Cancer Link
A New Jersey federal judge has thrown out a shareholder's derivative suit alleging Johnson & Johnson improperly sold talcum powder despite its purported cancer link, because the investor did not previously...To view the full article, register now.
Already a subscriber? Click here to view full article